Journal of immunological methods最新文献_第7页

Complement function and activation in human serum and plasma collected in different blood collection tubes 不同采血管采集的人血清和血浆的补体功能和活化。

IF 1.6 4区医学

Journal of immunological methods Pub Date : 2025-02-05 DOI: 10.1016/j.jim.2025.113825

Linnea I. Andersson , Dick J. Sjöström , Ricardo J.M.G.E. Brandwijk , Erik J.M. Toonen , Tom Eirik Mollnes , Per H. Nilsson

{"title":"Complement function and activation in human serum and plasma collected in different blood collection tubes","authors":"Linnea I. Andersson , Dick J. Sjöström , Ricardo J.M.G.E. Brandwijk , Erik J.M. Toonen , Tom Eirik Mollnes , Per H. Nilsson","doi":"10.1016/j.jim.2025.113825","DOIUrl":"10.1016/j.jim.2025.113825","url":null,"abstract":"<div><div>Complement analysis necessitates strict control of pre-analytical blood handling, including time, temperature, and additives. Here, we compared complement function and activation status across five different serum preparations and two plasma preparations. Serum was collected from ten healthy volunteers using glass tubes without additives, tubes with a silica clot activator (with or without a gel separator), and tubes containing thrombin (with or without a gel separator). Plasma was collected in the presence of EDTA or the thrombin inhibitor lepirudin. Serum and plasma aliquots were snap-frozen in liquid nitrogen and stored at −80 °C. Complement functional analysis was performed using Wieslab and Hycult Biotech pathway-specific assays. Complement activation was determined by quantifying specific activation markers: C1s/C1-INH, MASP-1/C1-INH, C3bc, C3bBbP, and sC5b-9. All serum samples exhibited increased complement activation compared to EDTA and lepirudin plasma, with serum tubes containing thrombin and gel separators showing the highest levels of complement activation. However, normal complement function was observed in all serum preparations, indicating that the complement activation and consumption that occurred did not affect complement functional analysis. While all tested serum tubes provided accurate functional activity, the type of tube and the presence of additives like thrombin and gel separators significantly influenced the degree of complement activation. We recommend preparing functionally active serum either in glass tubes or in silica clot activator tubes, and avoiding gel separators. For complement activation studies, lepirudin plasma is preferable over serum due to its complement functional capacity, low level of complement activation, and lack of excessive hemostatic activation.</div></div>","PeriodicalId":16000,"journal":{"name":"Journal of immunological methods","volume":"538 ","pages":"Article 113825"},"PeriodicalIF":1.6,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143374013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Basophil activation test; User's manual 嗜碱性粒细胞活化试验；用户手册。

IF 1.6 4区医学

Journal of immunological methods Pub Date : 2025-02-01 DOI: 10.1016/j.jim.2025.113815

Soren Ulrik Sonder , Matthew Plassmeyer , Nikhila Schroeder , Steven Peyton , Mikell Paige , Michael Girgis , Hamed Safi , Oral Alpan

{"title":"Basophil activation test; User's manual","authors":"Soren Ulrik Sonder , Matthew Plassmeyer , Nikhila Schroeder , Steven Peyton , Mikell Paige , Michael Girgis , Hamed Safi , Oral Alpan","doi":"10.1016/j.jim.2025.113815","DOIUrl":"10.1016/j.jim.2025.113815","url":null,"abstract":"<div><div>Immediate allergic responses, orchestrated by basophils and mast cells, are pivotal in severe allergic reactions. The flow cytometry-based Basophil Activation Test (BAT) is a clinically important assay for testing allergic reactions using CD63 and CD203c as endpoints. The test measures the concentration dependent response to the allergens providing a functional readout of the patients' allergies. BAT is presently in clinical use within the Unites States as well as several other countries for the diagnosis and monitoring of allergies, most commonly against food allergens. This article details assay validation, both analytical and clinical with reference to existing regulations/recommendations through CAP, CLIA, NYS and CLSI on issues including accuracy, precision, linearity, reportable range, reference range, analytical sensitivity & specificity, pre-analytical considerations, the utility of the assay in diagnosis or monitoring and interpretation of the results; and the assay's limitations.</div><div>The BAT plays a crucial role in assessing patient suitability for food challenges and therapies such as oral immunotherapy, sublingual immunotherapy or omalizumab and can aid in predicting treatment outcomes. We further review the current research on advancing the test, focused on improvements in its clinical utility. Continuous efforts are warranted for enhanced regulatory oversight and comprehensive clinical validation, ensuring BAT's seamless integration into diverse clinical settings.</div></div>","PeriodicalId":16000,"journal":{"name":"Journal of immunological methods","volume":"537 ","pages":"Article 113815"},"PeriodicalIF":1.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143039084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Clinical utility of the lymphocyte proliferation assay, an in vitro functional readout of the adaptive immune response 淋巴细胞增殖试验的临床应用，适应性免疫反应的体外功能读数。

IF 1.6 4区医学

Journal of immunological methods Pub Date : 2025-02-01 DOI: 10.1016/j.jim.2025.113819

Eszter Lázár-Molnár , Lisa K. Peterson

{"title":"Clinical utility of the lymphocyte proliferation assay, an in vitro functional readout of the adaptive immune response","authors":"Eszter Lázár-Molnár , Lisa K. Peterson","doi":"10.1016/j.jim.2025.113819","DOIUrl":"10.1016/j.jim.2025.113819","url":null,"abstract":"<div><div>Despite great advancements in the discovery of genetic variants underlying inborn errors of immunity, functional assessment of the immunological profile of patients in routine clinical practice remains challenging.</div><div>The lymphocyte proliferation assay using <sup>3</sup>H-thymidine incorporation has been the gold standard for decades for functional evaluation of T cells in the clinical laboratory, however, recently developed flow cytometric methods allowing for single cell analysis provide non-radioactive alternatives. Understanding the technical and analytical challenges of test development, validation and maintenance is essential for correct interpretation and test utilization, to assure appropriate and timely patient care. This review will discuss the technological aspects, validation and clinical utilization of <em>in vitro</em> lymphocyte proliferation assays performed in the clinical immunology laboratory, providing a diagnostic readout for T lymphocyte function, an essential hallmark of a functional cellular immune response, and allowing for the detection of impaired responses such as in patients with functional T cell defects.</div></div>","PeriodicalId":16000,"journal":{"name":"Journal of immunological methods","volume":"537 ","pages":"Article 113819"},"PeriodicalIF":1.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143039243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Overcoming cross-reactivity of antibodies against human lactate dehydrogenase 克服抗人乳酸脱氢酶抗体的交叉反应性。

IF 1.6 4区医学

Journal of immunological methods Pub Date : 2025-02-01 DOI: 10.1016/j.jim.2025.113821

Akira Kondo, Ayumu Nakamura

{"title":"Overcoming cross-reactivity of antibodies against human lactate dehydrogenase","authors":"Akira Kondo, Ayumu Nakamura","doi":"10.1016/j.jim.2025.113821","DOIUrl":"10.1016/j.jim.2025.113821","url":null,"abstract":"<div><div>Lactate dehydrogenase subunit A (LD-A) plays an important role in cancer regulation and therapy. We attempted to develop an enzyme-linked immune-solvent assay (ELISA) for LD-A in human serum.</div><div>However, commercial antibodies against LD-A exhibited cross-reactivity with an unknown protein. The unknown protein was purified and characterized by protein sequencing and Western blotting. In addition, we attempted to prepare a specific antibody for the ELISA using partially synthesized peptides of LD-A as immunogens. The epitope position in LD-A was carefully selected based on bioinformatics analysis.</div><div>Peptide sequencer elucidated a ten amino acid sequence of the purified protein at the N-terminal. A BLAST search revealed that this sequence perfectly matched that at the N-terminus of the IgG heavy chain (H-chain). Furthermore, we demonstrated that twelve commercially available antibodies targeting LD-A or LD-B (subunit B) primarily cross-reacted with IgG or its H-chain, with only one specific antibody for each subunit. As the specific antibody against LD-A is no longer commercially accessible, we successfully produced two kinds of specific antibodies using partially synthesized LD-A peptides as immunogens.</div><div>In conclusion, we have successfully produced specific antibodies against LD-A. Moreover, our findings underscore the utility of bioinformatics tools for determining the optimal positions of immunizing peptides.</div></div>","PeriodicalId":16000,"journal":{"name":"Journal of immunological methods","volume":"538 ","pages":"Article 113821"},"PeriodicalIF":1.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143123061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Diagnostic testing for hemophagocytic lymphohistiocytosis 噬血细胞淋巴组织细胞病的诊断试验。

IF 1.6 4区医学

Journal of immunological methods Pub Date : 2025-02-01 DOI: 10.1016/j.jim.2025.113816

Rebecca A. Marsh , Jack J. Bleesing , Samuel Cern Cher Chiang

引用次数: 0

Functional immunological assays 功能性免疫试验。

IF 1.6 4区医学

Journal of immunological methods Pub Date : 2025-02-01 DOI: 10.1016/j.jim.2025.113822

Attila Kumánovics , Medhat Askar , Amir A. Sadighi Akha

引用次数: 0

The Fas-mediated apoptosis assay: From concept to clinical application fas介导的细胞凋亡实验：从概念到临床应用。

IF 1.6 4区医学

Journal of immunological methods Pub Date : 2025-02-01 DOI: 10.1016/j.jim.2025.113812

Jack Bleesing

引用次数: 0

Regulatory requirements for laboratory developed tests in the United States 美国对实验室开发的测试的监管要求。

IF 1.6 4区医学

Journal of immunological methods Pub Date : 2025-02-01 DOI: 10.1016/j.jim.2025.113813

Shannon A. Bennett, Chelsea M. Conn, Hillary E. Gill, Brenda K. Holmen, Tasha M. McDevitt, Corrisa L. Miliander, Benjamin D. Uphoff, Curtis A. Hanson

引用次数: 0

Phospho-flow cytometry assays for diagnostic use – A discussion of assay utility and assay development and validation challenges 诊断用磷流式细胞术测定。测定效用和测定发展和验证挑战的讨论。

IF 1.6 4区医学

Journal of immunological methods Pub Date : 2025-02-01 DOI: 10.1016/j.jim.2025.113818

Vijaya Knight

引用次数: 0

Functional assays for the diagnosis of chronic granulomatous disease 慢性肉芽肿病诊断的功能测定。

IF 1.6 4区医学

Journal of immunological methods Pub Date : 2025-02-01 DOI: 10.1016/j.jim.2025.113820

Debra Long Priel, Karen Lau, Danielle L. Fink, Douglas B. Kuhns

引用次数: 0